POZEN Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment http://www.businesswire.com/news/home/20110323005170/en/POZEN-Announces-Licensing-Deal-Cilag-GmbH-Division